|Tradjenta||linagliptin||Brand||United Kingdom||5mg||28 Tablets||DR||$128.80||Add|
Medicines have benefits and some have risks. Always read the label and use only as directed. If symptoms persist or you have side effects see your health professional. Brands and generics both contain the same active ingredient(s) and are medically equivalent. Some brands are marketed under different names by the same manufacturing country depending on the country of origin.
Ships from the UK with tracking.
Tradjenta (linagliptin) is a type 2 diabetes medication that increases production of insulin in the pancreas while inhibiting production of the competing hormone glucagon. It gives patients better control of blood glucose levels, slowing or even halting progression of the disease and thereby reducing the likelihood of catastrophic complications like amputations or kidney failure.
The medication also slows gastric emptying, which in turn reduces the impact of a meal on blood glucose levels. This action has the added benefit of producing a feeling of satiety and fullness, which moderately decreases food intake in most patients; many patients lose weight while taking Tradjenta. Tradjenta also reduces liver fat content.
Used in conjunction with lifestyle changes such as diet and exercise, Tradjenta may reduce the need for supplemental injectable insulin therapy in type 2 diabetics; with sufficient lifestyle changes, and time for the body to respond to them, the need for medications may eventually be eliminated entirely.
Tradjenta is not intended for the treatment of Type I diabetes or ketacidosis.
What to Expect from Treatment
Tradjenta comes in tablets; no needles or injections to deal with. Treatment is very simple:
Tradjenta can be used on its own, but it is also often used with other diabetes medications, such as metformin. Other medications may call for adjusted doses; however, since Tradjenta is only available in 5 mg tablets, it's usually the other medications that are adjusted, not Tradjenta.
The medication will produce some results after the first dose; however it may take several days to several weeks to fully understand its impact, especially if other medications are being taken and their doses were adjusted to accommodate Tradjenta.
A particular benefit of Tradjenta, rare among anti-diabetic medications, is that it is not removed from the body through the kidneys, but rather through the gut. This means it can be used among those patients who have kidney damage---unfortunately a common complication of diabetes---that may make the majority of medications unsuitable.
Warnings & Side Effects
As always, blood glucose levels should be carefully monitored and any significant variation reported to a physician.
Tradjenta produces few side effects; most commonly reported are nausea, cold symptoms, and photosensitivity. Very rarely more serious side effects occur:
A doctor should be consulted as soon as possible if the above complications develop.
Januvia on its own is very unlikely to produce hypoglycemia (low blood glucose), but it is still a risk if other anti-diabetes medications are being taken.
Severe pancreatitis has been reported in patients taking Tradjenta, though it is unclear if Tradjenta is the cause. Patients should be alert for symptoms:
Because Tradjenta causes an increase in stomach emptying time, those who already have issues with delayed gastric emptying may want to consider alternate therapies. Slowed stomach-emptying may also cause increased absorption of other medications. Check with a doctor or pharmacist about taking any other medications along with Tradjenta.